drugset / Trial / NCT01258088

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

NCT01258088

Phase 1 Completed 16 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine how much drug is absorbed throughout the body after being applied to the skin.

Timeline

Start
2010-11-30
Primary completion
2010-12-07
Completion
2010-12-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Crisaborole Small molecule 5 unknown Topical

Indications